STOK Dividend History & Analysis | N/A Yield
STOK has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Biotechnology
| Symbol | Market Cap USD | Dividend Yield TTM | Yield on Cost 5y |
|---|---|---|---|
| ABBV | 387,093 M | 3.34% | 7.54% |
| AMGN | 198,244 M | 3.21% | 5.93% |
| GILD | 176,133 M | 2.79% | 5.63% |
| HLN | 46,623 M | 1.76% | 2.46% |
| BIM | 13,627 M | 0.74% | 0.75% |
| Symbol | Market Cap USD | Growth Rate | Consistency |
|---|---|---|---|
| BTX | 1,425 M | 134% | 95.6% |
| HLN | 46,623 M | 30.1% | 100% |
| AMGN | 198,244 M | 7.84% | 100% |
| BIM | 13,627 M | 9.76% | 96.0% |
| ABBV | 387,093 M | 5.98% | 100% |
Quality Dividend Peers in Biotechnology
3.21% Yield
2.79% Yield
STOK Dividend History: as of February 2026
No dividends paid yet.STOK Dividend FAQ
Stoke Therapeutics (NASDAQ: STOK) is an early-stage biotech that pursues a “Targeted Augmentation of Nuclear Gene Output” (TANGO) platform to up-regulate deficient proteins using antisense oligonucleotides (ASOs). Its pipeline centers on STK-002 (pre-clinical for autosomal dominant optic atrophy) and Zorevunersen (STK-001), an ASO in a combined Phase I/II study for Dravet syndrome. The company also holds collaborations with Biogen (Dravet program) and Acadia Pharmaceuticals (RNA-based neurodevelopmental diseases).
What is the Dividend Yield of STOK?
As of February 2026, STOK`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 32.40.Does STOK pay a dividend?
As of February 2026 STOK does not pay a dividend.How often does STOK pay dividends?
Over the last 12 months, STOK has issued dividend payments.STOK dividend forecast
Based on historical data, the forecasted dividends per share for STOK for the next 4 payments are between 0 (+0.0%) and 0 (+0.0%).This suggests the dividend will remain relatively stable.
Will STOK pay dividends in 2026?
The next Ex-Dividend date for Stoke Therapeutics (STOK) is currently unknown.What is the next Ex-Dividend Date for STOK?
The next Ex-Dividend date for Stoke Therapeutics (STOK) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of STOK?
STOK's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of STOK?
STOK's 5-Year Yield on Cost is -%. If you bought STOK's shares at 66.71 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of STOK?
STOK Payout Consistency is 0.0%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does STOK have a good Dividend Yield?
STOK`s % Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of STOK?
The Dividend Payout Ratio of STOK is unknown.What is the Dividend Rating of STOK?
STOK`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield
- Annual dividend per share divided by current share price.
- Payout Ratio
- Percentage of earnings paid as dividends. Below 60% = safe, above 100% = unsustainable.
- Payout FCF
- Percentage of Free Cash Flow paid as dividends. More reliable than Payout Ratio since it measures actual cash.
- Growth Rate (CAGR)
- Compound annual growth rate of dividends over the last 5 years.
- Consistency
- Reliability of dividend payments over lifetime. Penalizes cuts and pauses.
- Yield on Cost
- Your effective yield if you bought 5 years ago. Shows dividend growth impact over time.
- Streak
- Consecutive years of dividend payments. 25+ years = Dividend Aristocrat.
- Dividend Rating
- Proprietary score (0-100) combining yield, growth, safety and consistency.
Last update: 2026-02-01 02:19